A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

This study has been completed.

Study NCT00145171 Information provided by Mylan Bertek Pharmaceuticals

First Received: September 2, 2005 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2002
Estimated Primary Completion Date:	No date given